Our Science – Dudley Website
Mark E. Dudley, Ph.D.
The Cell Production Facility serves as a conduit between the Surgery Branch basic research laboratories and the patient clinics. Our mandate is to translate new research findings into successful gene therapy and cell based treatments for patients with cancer. Current efforts focus on clinical scale platforms for lymphocyte cell culture including closed bioreactors, retroviral and lentiviral gene therapy vectors, and artificial antigen presenting cells. These systems are being developed in the context of ongoing clinical trials to treat patients with advanced melanoma and other cancers.
This page was last updated on 2/21/2013.